selected publications

• article

  • A comparative study of PF-06438179/GP1111 (an infliximab biosimilar) and reference infliximab in patients with moderate to severe active rheumatoid arthritis: A subgroup analysis.  International Journal of Rheumatic Diseases.  23:876-881. 2020-01-01